David Davidar - GLOBUS MEDICAL Independent Director
| GM0N Stock | EUR 75.00 1.00 1.35% |
Insider
David Davidar is Independent Director of GLOBUS MEDICAL A since 2016.
| Age | 53 |
| Tenure | 9 years |
David Davidar Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Davidar against GLOBUS MEDICAL stock is an integral part of due diligence when investing in GLOBUS MEDICAL. David Davidar insider activity provides valuable insight into whether GLOBUS MEDICAL is net buyers or sellers over its current business cycle. Note, GLOBUS MEDICAL insiders must abide by specific rules, including filing SEC forms every time they buy or sell GLOBUS MEDICAL'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Davidar over three months ago Acquisition by David Davidar of 15000 shares of Globus Medical at 92.42 subject to Rule 16b-3 |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Sitra Horsinchai | Thai Beverage Public | N/A | |
| Hongying Lin | Zijin Mining Group | 55 | |
| Khunying Sirivadhanabhakdi | Thai Beverage Public | 80 | |
| Jinghe Chen | Zijin Mining Group | 66 | |
| Weiyong Wang | China Resources Beer | 57 | |
| Jason Weidman | ScanSource | N/A | |
| Longshan Zhou | China Resources Beer | 62 | |
| Mark Morgan | ScanSource | N/A | |
| Xianliang Wang | China Resources Beer | 62 | |
| Dan Zhu | China Resources Beer | 61 | |
| Laichang Zou | Zijin Mining Group | 55 | |
| Stephen Jones | ScanSource | 51 | |
| Hongfu Lin | Zijin Mining Group | 49 | |
| Kosit Suksingha | Thai Beverage Public | 57 | |
| Banjong Chintanasiri | Thai Beverage Public | 65 | |
| Cheung Fan | Zijin Mining Group | 63 | |
| Jianhui Wu | Zijin Mining Group | N/A | |
| Qiang Wei | China Resources Beer | 53 | |
| John Eldh | ScanSource | 55 | |
| Xionghui Xie | Zijin Mining Group | 49 | |
| Gregory Dixon | ScanSource | N/A | |
GLOBUS MEDICAL A Leadership Team
Elected by the shareholders, the GLOBUS MEDICAL's board of directors comprises two types of representatives: GLOBUS MEDICAL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GLOBUS. The board's role is to monitor GLOBUS MEDICAL's management team and ensure that shareholders' interests are well served. GLOBUS MEDICAL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GLOBUS MEDICAL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steve Zarrilli, Independent Director | ||
| David Paul, Executive Chairman of the Board | ||
| James Tobin, Independent Director | ||
| Robert Douglas, Independent Director | ||
| Ann Rhoads, Independent Director | ||
| Daniel Lemaitre, Independent Director | ||
| Keith Pfeil, Chief Financial Officer, Senior Vice President | ||
| David Demski, President, Chief Executive Officer, Director | ||
| Kelly Huller, Senior Vice President General Counsel, Corporate Secretary | ||
| Daniel Scavilla, Executive Vice President Chief Commercial Officer | ||
| David Davidar, Independent Director |
GLOBUS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GLOBUS MEDICAL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 6.66 B | |||
| Price To Book | 4.15 X | |||
| Price To Sales | 7.57 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 304.5 M | |||
| Net Income | 190.17 M | |||
| Cash Flow From Operations | 178.47 M | |||
| Price To Earnings To Growth | 2.80 X | |||
| Number Of Employees | 12 | |||
| Market Capitalization | 6.1 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price |
Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.